Indeed, high s-IGF-II has been reported to be correlated with cancer risk, especially colorectal, breast, prostate, lung, and colon cancer [32], and low s-IGF-II has been correlated with colorectal cancer mortality [33]. This evidence concerns the gene IGF2 and colonic neoplasm.